Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
PhD Thesis based on ABIS. The main areas have so far been studies on the development of Type 1 diabetes, but also studies on celiac disease, JIA, IBD, autism, obesity, allergy and recently also
-
-scale genetic variability, archaeal diversity and microbial lineages involved in anaerobic diagenesis. You will also be involved in the supervision of PhD, Master and Bachelor students, and assist in
-
organoids will be plus. Dry lab: Highly motivated candidates with a PhD/MD degree in bioinformatics, genome science, systems biology, biomedical informatics, computational biology, machine learning, data
-
has a PhD and experience in the field of cell and gene therapy for cancer and who has recent experience of primary T cell culture, CARTs, immune assays, flow cytometry, molecular cloning, retroviral
-
List of Publications please visit here . Your qualifications should include: · PhD or M.D. Expertise in using mouse models to study metabolic diseases is preferred. · Extensive experience
-
to produce neoantigen vaccines for patients at medical centers nationally as a primary goal. Your qualifications should include: · PhD degree in an appropriate discipline such as cellular or tumor
-
, with a strong background in experimental neurobiology, molecular biology, we want to hear from you. Your unique experiences and perspectives are invaluable to our team. Profile PhD in Biology
-
transition is possible, again subject to review. The ideal candidate: The successful candidate will have a PhD or equivalent in a relevant subject to the role. They will also have substantial postdoctoral
-
and synthesis of new materials. You should have a PhD in a relevant field (Computer Science, Mathematics are most likely to fit the role, but we are open to Chemistry, Materials Science, Chemical
-
conduct laboratory-based research focusing on multiple myeloma and its precursor conditions. Based on the mission of the lab, the successful candidate will be responsible for identifying novel biomarkers